Firebrick Pharma Ltd Requests Trading Halt
Key points
- Firebrick Pharma Ltd requests trading halt pending announcement
- Trading halt to remain in place until earlier of market open on 31 March 2026 or announcement release
- Company not aware of any reason why trading halt should not be granted
Full summary
Firebrick Pharma Ltd (ASX: FRE) has requested an immediate trading halt in its securities pending the release of an announcement. The company has requested the trading halt under ASX Listing Rule 17.1, stating that the halt is pending an announcement regarding a placement. The trading halt will remain in place until the earlier of the commencement of normal trading on Tuesday, 31 March 2026, or the release of the announcement to the market. Firebrick Pharma Ltd has confirmed that it is not aware of any reason why the trading halt request should not be granted and that there is no other information necessary to inform the market about the trading halt.
Summary generated by a large language model. Please interpret with care.